Southeast Missouri Hospital
Cape Girardeau, Missouri, United States
Hospital in Cape Girardeau, Missouri
1701 Lacey St, Cape Girardeau, MO 63701
About Southeast Missouri Hospital
Southeast Hospital is a private, not-for-profit hospital located in Cape Girardeau, Missouri. Southeast Missouri Hospital first opened in 1928 and has grown into a regional medical complex serving over 600,000 people in 22 counties in Southeast Missouri and Southern Illinois.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
25
Alliance for Clinical Trials in Oncology
2
ECOG-ACRIN Cancer Research Group
1
GOG Foundation
1
Gynecologic Oncology Group
1
Clinical Trials at Southeast Missouri Hospital
During the past decade, Southeast Missouri Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 20 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
2004-08-15
Active, not recruiting
406
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2005-09-01
2015-04-01
Completed
1,873
Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
2007-08-01
2011-01-01
Completed
109
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
2006-02-17
2019-02-11
Terminated
355
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Southeast Missouri Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 25 trials, followed by "Alliance for Clinical Trials in Oncology" with 2 trials
sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored, "GOG Foundation" with 1 trials sponsored and "Gynecologic Oncology Group"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Southeast Missouri Hospital"
#1 collaborator was "Cancer and Leukemia Group B" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 2 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Southeast Missouri Hospital
According to Clinical.Site data, the most researched conditions in "Southeast Missouri Hospital" are
"Recurrent Breast Carcinoma" (4 trials), "Stage IIIB Breast Cancer AJCC v7" (4 trials), "Stage IIIC Breast Cancer AJCC v7" (3 trials), "Stage IV Breast Cancer AJCC v6 and v7" (3 trials) and "Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11" (2 trials). Many other conditions were trialed in "Southeast Missouri Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Southeast Missouri Hospital
Most popular intervention types in "Southeast Missouri Hospital" are "Drug" (28 trials), "Other" (22 trials), "Biological" (15 trials), "Radiation" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Bevacizumab" (9 trials), "Quality-of-Life Assessment" (9 trials), "Paclitaxel" (5 trials) and "Carboplatin" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Southeast Missouri Hospital
The vast majority of trials in "Southeast Missouri Hospital" are
23 trials for "All" genders and 7 trials for "Female" genders.
Clinical Trials Status at Southeast Missouri Hospital
Currently, there are NaN active trials in "Southeast Missouri Hospital".
undefined are not yet recruiting,
undefined are recruiting,
15 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Southeast Missouri Hospital,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Southeast Missouri Hospital, 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 23 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Southeast Missouri Hospital
Southeast Missouri Hospital has several departments that took part in Clinical trials: "Southeast Cancer Center" - 307 trials
Departments List
Name
City
Trials